About Veritas in Silico Inc. Veritas In Silico Inc. engages in the development of molecular medicine drugs. It provides a platform business for the discovery of mRNA-targeted small molecule and ...
Flusiva is the first FDA-approved seasonal influenza vaccine to use mRNA technology. Beyond influenza itself, how significant is this approval for the future development of vaccines and infectious ...
ZME Science on MSN
The US just approved its first mRNA flu vaccine. Is this a new era?
For the first time, the United States has an mRNA flu shot. The FDA has cleared Moderna’s mFlusiva for adults aged 50 and ...
There are issues with side effects: two-thirds of recipients reported injection-site pain, against 30 percent for the ...
The FDA approved an mRNA seasonal influenza vaccine offering enhanced protection for adults aged 50 years or older compared with standard vaccines. The Conversation — Vaccines have been reliably and ...
The FDA approved Moderna’s flu vaccine mFLUSIVA, a regulatory decision that comes six months after the agency refused to ...
The Food and Drug Administration has approved a new influenza vaccine for older adults manufactured by Moderna. The shot ...
As Pfizer and Moderna have tied off certain threads in their separate webs of mRNA patent litigation, Sanofi has opened a new front to challenge the companies’ blockbuster COVID-19 vaccines. In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results